Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
14.87
+0.17 (1.16%)
At close: Oct 15, 2026, 4:00 PM EDT
15.09
+0.22 (1.48%)
After-hours: Oct 15, 2026, 4:42 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $5.2 billion as of October 15, 2026. It is the 3,517th most valuable company in the world and the 1,117th biggest in the United States. Its market cap has increased by 660.77% in one year.
Market Cap
5.20B
Enterprise Value
4.86B
1-Year Change
660.77%
Global Rank
Country Rank
#1,117 United States
Category
ChartMarket Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $5.20B, an increase of 179.88%. That is a compound annual growth rate of 21.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 5.20B | 392.79% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 5.75B |
| CG Oncology | 5.53B |
| Oruka Therapeutics | 5.18B |
| Mirum Pharmaceuticals | 5.17B |
| PTC Therapeutics | 5.00B |
| Scholar Rock Holding | 4.93B |
| Travere Therapeutics | 4.88B |
| Cogent Biosciences | 4.88B |